The US FDA conducted the inspection from Aug. 4, 2025 to Aug. 12, 2025 excluding the weekend of Aug. 9 and 10, 2025, (Photo source: Freepik) Show Quick Read Summary is AI Generated. Newsroom Reviewed

Cohance Lifesciences Ltd. announced on Sunday that the company received an 'Official Action Indicated' report along with six observations from the US Food and Drug Administration for its Finished Dosage Formulations Manufacturing Facility in Nacharam, Hyderabad.

The US FDA conducted the inspection from Aug. 4, 2025 to Aug. 12, 2025 excluding the weekend of Aug. 9 and 10, 2025, according to exchange filings from the company.

"The company is engaging proactively with the USFDA and has initiated a comprehensive remediation program and align the facility fully with global standards. The FD

See Full Page